Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.
about
Extinction of conditioned opiate withdrawal in rats in a two-chambered place conditioning apparatus.Glucocorticoids regulation of FosB/ΔFosB expression induced by chronic opiate exposure in the brain stress systemHypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawalRole of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc)Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons functionAcute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP.Acute morphine associated alterations in the subcellular location of the AMPA-GluR1 receptor subunit in dendrites of neurons in the mouse central nucleus of the amygdala: comparisons and contrasts with other glutamate receptor subunitsRepeated episodes of heroin cause enduring alterations of circadian activity in protracted abstinence.Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats.Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.Role of NK-1 neurotransmission in opioid-induced hyperalgesiaNeuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawalExtinction of conditioned opiate withdrawal in rats is blocked by intracerebroventricular infusion of an NMDA receptor antagonist.Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.Blockade of PDGFR-β activation eliminates morphine analgesic tolerancePersistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate WithdrawalLateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference.TRPV1 receptor in expression of opioid-induced hyperalgesiaNucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in RatsFunctional internal complexity of amygdala: focus on gene activity mapping after behavioral training and drugs of abuse.D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats.Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrainIncentive learning for morphine-associated stimuli during protracted abstinence increases conditioned drug preference.Synthesis and evaluation of a series of 3,4,5-trimethoxycinnamic acid derivatives as potential antinarcotic agents.Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain.Memories of Opiate Withdrawal Emotional States Correlate with Specific Gamma Oscillations in the Nucleus Accumbens.Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal.Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal.CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.Crosstalk between G protein-coupled receptors (GPCRs) and tyrosine kinase receptor (TXR) in the heart after morphine withdrawalLocal opiate withdrawal in locus coeruleus neurons in vitro.Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.Enhanced morphine preference following prolonged abstinence: association with increased Fos expression in the extended amygdala.Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA.Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors.Altered motivation and learning following opiate withdrawal: evidence for prolonged dysregulation of reward processing.Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.
P2860
Q27310390-50558DB2-542E-44BB-8A16-5F8EA434665BQ27334348-C069A596-62D3-4705-9407-C4396F22B7F3Q28483614-2D0E64A4-117C-4C0A-B4F6-D0941EC865E6Q28484325-AC6F1DD7-7877-4808-B787-0676C14D9483Q28583554-4720D8EE-796E-4F7D-9FBE-B6CF54720577Q33709318-F5057C76-6A72-4A78-B296-D36783B82495Q33769345-AB5D1EEA-EEA1-4BD4-97FC-F87EB9C5A1A9Q33771947-E9A8EB9C-799D-4571-B49C-B3FC903AA699Q34065808-9307700D-40DC-424D-B14B-4F68D25A2001Q34320180-67323018-A2B6-4CB1-8E8D-400645AAAB76Q34545402-3D32C85A-FECB-44C9-8074-17BB73D1ECA4Q35050888-8212955C-6DF1-481C-8C83-B2C099F65BF8Q35662255-7D5DD377-4F3E-46C2-84A9-B08621552E4EQ35671087-189C6436-FEFC-4EF6-9D6F-47729178FEF8Q35765718-77BD4D44-C6C3-4F1D-B9AB-004CBA89038AQ35812604-60B72A62-6264-4C70-AB01-8178B0368472Q35851528-D757E6D4-8732-424E-911F-F46AC51CC424Q35875205-92AFDC48-D32E-48FB-B737-722A1C4EF875Q36066010-2D7AAD07-2F53-43DA-A73B-BEFB0B74D6A4Q36932893-2C9EBF91-2037-454C-B83B-C577CD255D5EQ36967668-CC32A4F7-2ABE-4418-A1BA-97A3C0397F4DQ37126364-70EF8602-3F8B-4698-8993-DE21EB2200CDQ37240000-B4981590-BC13-41A0-97A2-9652DBDFD162Q37409565-63DD66FA-27FD-4F91-BEE1-114005CD6E4FQ38456816-E838AFB9-ADCC-4754-87B9-E8114E7802B0Q38861751-EEC86435-D2F7-4BFF-ADD4-00EDD5CC84AFQ40990836-A532D750-8F8F-42B5-BB04-F42076D9DFC3Q41654668-5BCB8286-A930-44B8-B6FB-4E59DB7654E0Q41672595-A09AB97A-20D6-4456-8A86-A481976B3A4FQ41924903-C17591C8-F6DA-456F-AC1F-11BA10C4191DQ42618279-2AF6FE09-7C75-4FF3-8725-8919AE9BF3C7Q42774583-F3013D2D-8C89-468A-82ED-1163D413FE20Q43626772-E9860E4C-2330-405A-8904-6FE7BE1AC329Q44197990-A1269A22-33CC-4419-B999-FC5D4A51E584Q44317354-CE4C5A85-67AD-4A64-BE87-5097D117B0D0Q44317360-7B43B940-5269-46FF-A22D-1F79D28101EFQ44357517-79A32D46-E33E-4DA8-BAE2-50252D3D6F20Q44407129-CEBA7999-575D-498B-AEBB-01C2D91D8B9CQ44433751-78C8CCD0-1A55-4824-89D5-BCCC22444017Q45063674-33A58A84-C8F3-4162-B7BA-5ED6C4D4F326
P2860
Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Prolonged tolerance, dependenc ...... ellet implantation in the rat.
@en
type
label
Prolonged tolerance, dependenc ...... ellet implantation in the rat.
@en
prefLabel
Prolonged tolerance, dependenc ...... ellet implantation in the rat.
@en
P2093
P1476
Prolonged tolerance, dependenc ...... ellet implantation in the rat.
@en
P2093
P356
10.1016/0014-2999(94)90755-2
P407
P577
1994-02-01T00:00:00Z